As the dominant G-actin sequestering protein in mammalian cells, TB-500 binds globular actin with high affinity (Kd ~0.5 M) through a sophisticated triple-contact mechanism involving Lys-3, Lys-18, and Lys-38 residues, preventing spontaneous actin polymerization while maintaining a readily mobilizable reservoir for rapid cytoskeletal reorganization
Store Properly: Keep reconstituted peptide refrigerated and protected from light
TB-500 does not have an FDA-approved dosage because it is not FDA-approved as a drug
No peer-reviewed publication has measured the nasal bioavailability of BPC-157 in any species
The reality of oral administration for musculoskeletal indications is straightforward: the peptide disperses through the digestive system before it reaches the injury site, and what arrives at a tendon or joint after that journey is a fraction of what a subcutaneous injection placed near the tissue delivers
The copper component can cause localized burning, redness, or irritation in some individuals